AGI-6780 - Mutant IDH2 Inhibitor. CAS# 1432660-47-3 60218 and induces G2/M-phase growth arrest

and induces G2/M-phase growth arrest and cell death through the induction of apoptosis

Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4

Formula: C17H25N3O

but not to vascular smooth muscle and endothelial cells

AGI-6780 - Mutant IDH2 Inhibitor. CAS# 1432660-47-3 60218 and induces G2/M-phase growth arrestAGI 6780, CAS No. 1432660 47 3, is a potent and selective IDH2 inhibitor. AGI 6780 inhibits the tumor associated mutant IDH2 R140Q. Treatment with AGI 6780 induced differentiation of TF 1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. Inhibitors targeting mutant IDH2 R140Q could have potential applications as a differentiation therapy for cancer. Product information CAS Number: 1432660 47 3 Molecular Weight: 481. 51